Search Results 51-60 of 88 for Oral

  1. Winston Tan, M.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research

    Focus areas Developing novel hormonal strategies to abrogate the pathway of resistance in breast cancer, prostate cancer and bladder cancer Identifying molecular markers that will predict response and toxicity to targeted treatment Identifying and de...

  2. Academic Milestones - Center for Clinical and Translational Science - Center for Clinical and Translational Science (CCaTS)

    Year 3 Complete your Oral Qualifying Exam by Oct. 1.

  3. Careers and Education - Knowledge and Evaluation Research Unit - Mayo Clinic Research

    Knowledge of health services and clinical research methodology, adequate written and oral communication skills, and a commitment to teamwork are required.

  4. Metformin as a Metabolic Therapeutic in Ovarian Cancer - Mayo Clinic Cancer Center Research - Mayo Clinic Research

    Independent retrospective analyses by investigators at the University of Chicago and Mayo Clinic have shown that administration of metformin, an oral biguanide prescribed for patients with diabetes to improve glycemic control, is ass...

  5. Marie C. Hogan, M.D., Ph.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research

    s this goal are funded by: Analysis of the proteome of PKD-ELVs in polycystic kidney disease and controls American Recovery and Reinvestment Act (ARRA)GRANT 10266762; 1RC1DK086161-01 The PKD Foundation (ADPKD Pain Study) Industry (Tolvaptan Efficacy ...

  6. Joel M. Reid, Ph.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research

    Reid's laboratory include: The first chemoprevention phase 0 exploratory pharmacokinetic clinical trial (first-in-man) of the Akt inhibitor SR13668 to establish a formulation with the best oral bioavailability Characterization of the...

  7. Martin D. Zielinski, M.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research

    In addition, he is actively studying the effects that oral contrast agents, such as Gastrografin, have on the diagnosis and treatment of small bowel obstruction.

  8. Inhibition of SCD1 As a Therapeutic Strategy for Hepatocellular Carcinoma - Mayo Clinic Cancer Center Research - Mayo Clinic Research

    SSI-4 has excellent oral bioavailability and is well tolerated with long-term daily dosing.

  9. Lung Cancer and Other Tobacco-Related Diseases - Nicotine Research Program - Mayo Clinic Research

    Smoking and other types of tobacco use also increase the risk of a number of other cancers, including lip, oral cavity, pharynx, esophagus, pancreas, voice box (larynx), cervix, urinary bladder and kidney cancers.

  10. Musculoskeletal Research Training Program - Mayo Clinic

    -Ph.D. student at Mayo Clinic Alix School of Medicine who is performing clinical or basic research in a musculoskeletal area Ideally have passed their written and oral qualifying exams in Mayo Clinic Graduate School of Biomedical Sci...